Weiyun Z. Ai, PhD, MD

Beijing University, China, Bsc, 1984-1987, Cell Biology and Genetics
Columbia University Medical School, New York, 1987-1989, Microbiology & Immunology
Stanford University School of Medicine, California, PhD, 1989-1995, Microbiology & Immunology
Stanford University School of Medicine, California, MD, 1996-2000, Medicine

• 06/93 - 09/93
  Bayer Pharmaceuticals, Kobe, Japan, Research associate, Molecular Biology Laboratory of Pharmacology Institute
• 06/00 - 06/01
  University of California, San Francisco, San Francisco, CA, Internship in Internal Medicine
• 07/01 - 06/02
  University of California, San Francisco, San Francisco, CA, Residency in Internal Medicine
• 07/02 - 06/05
  Stanford University, School of Medicine, Stanford, CA, Clinical fellow in medical oncology
• 07/03 - 09/03
  University of California, San Francisco, San Francisco, CA, Visiting oncology fellow on Bone Marrow Transplant Service
• 07/05 - 12/06
  Stanford University, School of Medicine, Stanford, CA, Postdoctoral research fellow in immunotherapy in Dr. Ronald Levy's laboratory
• 03/06 - 12/06
  Stanford University, School of Medicine, Stanford, CA, Instructor in medical oncology
• 01/07 - present
  University of California, San Francisco, San Francisco, CA, Clinical Assistant Professor, Division of Hematology/Oncology

• 1997
  Beckman Scholar, Stanford University
• 1998
  Dean's Scholar, Stanford University
• 2005
  Young Investigator Award by American Society of Clinical Oncology (ASCO)
• 2005
  Lisa Beth Fishman Memorial Fellow of Lymphoma Research Foundation (2005-2007)
• 2006
  Travel Award by American Society of Hematology (ASH)
• 2006
  Brigid G. Leventhal Scholar Awards by American Association for Cancer Research (AACR)

• Dingwall, A., Zhuang, W., Quon, K., Shapiro, L.: Expression of an early gene in the flagellar regulatory hierarchy is sensitive to an interruption in DNA replication. Journal of Bacteriology, 174:1760-1768, 1992.
• Zhuang, W., Shapiro, L.: Caulobacter FliQ and FliR membrane proteins, required for flagellar biogenesis and cell division, belong to a family of virulence export proteins. Journal of Bacteriology, 177:343-356, 1995.
• Zhuang, W. et. al: The susceptibility of muscle cells to oxidative stress is independent of nitric oxide synthase expression. Muscle & Nerve, April, 2001: 502-511
• Advani, R., Ai, Weiyun Z., and Sandra J. Horning: Management of advanced Hodgkin's disease. Journal of the National Comprehensive Cancer Network (JNCCN), 4:241-247, 2006.
• Olga K. Weinberg, Weiyun Z. Ai, M. Rajan Mariappan, Carol Shum, Ronald Levy, Daniel A. Arber. 2007 "Minor" BCL2 breakpoints in follicular lymphoma: Frequency and correlation with grade and disease presentation in 236 cases. Journal of Molecular Diagnostics, accepted. Epub July 25, 2007.
• Ai, Weiyun Z., Tibshirani, R., Taidi B., Czerwinski, D., and Ronald Levy: Induction of anti-idiotype antibody through vaccination correlates with better survival in follicular lymphoma. Submitted. 2007
• ABSTRACTS:
• Zhuang, W., Shapiro, L.: FliQR: an early expressed operon in C. crescentus flagellar biogenesis. Poster presentation, American Society of Microbiology Annual Conference, 1992
• Ai, Weiyun Z., Czerwinski, D., Holmes, T., Tibshirani, R., Horning, S., and Ronald Levy: The Percentage of Tumor-infiltrating T cells Is Not Correlated with Overall Survival in Follicular B-cell Lymphomas. Poster presentation, at American Society of Hematology Annual Meeting 2004
• Ai, Weiyun Z., Kim, Youn, Hoppe, R. T., Shah, S., Horning, S. J., Tibshirani, R., and Ronald Levy Preliminary Report on a Phase I/II Study of Intratumoral Injection of PF-3512676 (CpG 7909), a TLR9 Agonist, Combined with Radiation in Recurrent Low-grade Lymphomas. Poster presentation, American Society of Hematology Annual Meeting 2006
• Ai, Weiyun Z., Czerwinski, D., Horning, S.J., Allen, J., Tibshirani, R., and Ronald Levy: Tumor- infiltrating T cells are not predictive of clinical outcome in follicular lymphoma. Oral presentation, American Society of Hematology Annual Meeting 2006
• Ai, Weiyun Z., Hsu, F., Timmermen, J., Czerwinski, B., Taidi, B., Levy, R., Sandra J. Horning: Alternating CVP with fludarabine chemotherapy prior to idiotype vaccination for follicular lymphoma. Poster presentation, American Association of Clinical Oncology Annual Meeting 2007
• A Morales, W Ai, RT Hoppe, S Shah, R Levy, and YH Kim. Novel in situ vaccination with intratumoral injection of CpG 7909, a TLR 9 agonist, combined with radiation in mycosis fungoides and primary cutaneous B-cell lymphoma. American Academy of Dermatology Annual Meeting, 2007